To detect functional somatic mutations in tumor samples, whole-exome sequencing (WES) is often used for its reliability and relative low cost. RNA-seq, while generally used to measure gene expression, can potentially also be used for identification of somatic mutations. However there has been little systematic evaluation of the utility of RNA-seq for identifying somatic mutations. Here, we develop and evaluate a pipeline for processing RNA-seq data from glioblastoma multiforme (GBM) tumors in order to identify somatic mutations. The pipeline entails the use of the STAR aligner 2-pass procedure jointly with MuTect2 from GATK to detect somatic variants. Variants identified from RNA-seq data were evaluated by comparison against the COSMIC and dbSNP databases, and also compared to somatic variants identified by exome sequencing. We also estimated the putative functional impact of coding variants in the most frequently mutated genes in GBM.
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Variants included in the set of 29 GBM-related genes and not included in COSMIC or dbSNP are shown, although COSMIC contained alternative variants at the same positions for four mutations that were found by RNA-seq-only. For SIFTindel and FATHMM indels, the score is given as a confidence score. AF (tumor) shows the proportion of altered reads in tumor samples, with Coverage (tumor) being the total number of reads at the variant position.
Allele Fraction and Coverage was used to further exclude potential artifacts, which are not listed here. 
